NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed Jun 24, 2013
Insider Transaction Report
Form 4
Shreiner Jay W
Director
Transactions
- Award
Stock Option (Right to Buy)
2013-06-20+16,063→ 16,063 totalExercise: $14.12From: 2013-06-20Exp: 2018-06-19→ Common Stock (16,063 underlying)
Footnotes (1)
- [F1]Pursuant to the issuer's director compensation policy, the stock option reported on this Form 4 was immediately exercisable as of the grant date for all shares of common stock that may be purchased under such stock option.